(Q38365097)

2 September 2017

1 reference

title

Ventricular arrhythmias in congestive heart failure (English)

1 reference

2 September 2017

0 references

congestive heart failure

1 reference

Chakko S

1

1 reference

2 September 2017

de Marchena E

series ordinal

2

1 reference

2 September 2017

Kessler KM

series ordinal

3

1 reference

2 September 2017

Myerburg RJ

series ordinal

4

1 reference

2 September 2017

1 September 1989

1 reference

2 September 2017

1 reference

2 September 2017

12

1 reference

2 September 2017

9

1 reference

2 September 2017

525-530

1 reference

The effects of digitalis on survival in high-risk patients with coronary artery disease. The Coronary Artery Surgery Study (CASS).

2 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960120910

Are beta-adrenergic-blocking drugs useful in the treatment of dilated cardiomyopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960120910

The Natural History of Congestive Heart Failure: The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960120910

7 January 2021

Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960120910

7 January 2021

Significance of ventricular tachycardia in idiopathic dilated cardiomyopathy: Observations in 35 patients

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960120910

7 January 2021

Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960120910

7 January 2021

Ventricular arrhythmias in severe heart failure: incidence, significance, and effectiveness of antiarrhythmic therapy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960120910

7 January 2021

Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960120910

7 January 2021

Arrhythmias in ischemic and nonischemic dilated cardiomyopathy: prediction of mortality by ambulatory electrocardiography

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960120910

7 January 2021

Factors influencing the one-year mortality of dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960120910

7 January 2021

Ventricular arrhythmias in idiopathic dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960120910

7 January 2021

Antiarrhythmic therapy for asymptomatic ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960120910

7 January 2021

Classification of ventricular arrhythmias based on parallel hierarchies of frequency and form

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960120910

7 January 2021

Prediction of serious arrhythmic events after myocardial infarction: signal-averaged electrocardiogram, Holter monitoring and radionuclide ventriculography

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960120910

7 January 2021

Prevalence of late potentials in patients with and without ventricular tachycardia: correlation with angiographic findings

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960120910

7 January 2021

Pharmacologic approaches to management of arrhythmias in patients with cardiomyopathy and heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960120910

7 January 2021

Digitalis-associated cardiac mortality after myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960120910

7 January 2021

Prognostic importance of digitalis after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960120910

7 January 2021

Digoxin therapy and mortality after myocardial infarction. Experience in the MILIS Study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960120910

7 January 2021

Effect of digitalis treatment on survival after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960120910

7 January 2021

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960120910

7 January 2021

Do positive inotropic agents adversely affect the survival of patients with chronic congestive heart failure? I. Introduction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960120910

7 January 2021

Effects of milrinone on complex ventricular arrhythmias in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960120910

7 January 2021

Effect of propranolol after acute myocardial infarction in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960120910

7 January 2021

Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960120910

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960120910

7 January 2021

Congestive heart failure and arrhythmias: an overview

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960120910

7 January 2021

Should asymptomatic ventricular arrhythmias in patients with congestive heart failure be treated with antiarrhythmic drugs?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960120910

7 January 2021

Clinical characteristics of patients with ventricular fibrillation during antiarrhythmic drug therapy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960120910

7 January 2021

Pharmacokinetics and pharmacodynamics of antiarrhythmic agents in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960120910

7 January 2021

Automatic implantable cardioverter defibrillators and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960120910

7 January 2021

Identifiers

DOI

10.1002/CLC.4960120910

1 reference

2 September 2017

1 reference